Gregory W. Schafer, a member of the Board of Directors of Capricor Therapeutics, Inc., has notified the company that he will not stand for re-election when his term on the Board expires at the company's 2016 Annual Meeting of Stockholders, which is scheduled for June 2, 2016. Mr. Schafer will continue to serve as a member of the Board, as the Chairman of the Audit Committee of the Board and as a member of the Nominating and Corporate Governance Committee of the Board until the Annual Meeting. Mr. Schafer's decision not to stand for re-election is not due to any disagreement with the Company on any of the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.25 USD | -0.64% | +17.26% | +27.81% |
05-17 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
05-13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.81% | 198M | |
+9.99% | 114B | |
+12.01% | 107B | |
-3.07% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-6.90% | 17.51B | |
-39.36% | 17.17B | |
+5.82% | 14.14B | |
+33.05% | 12.2B |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Gregory W. Schafer Not Stand for Re-Election as Member of the Board of Directors of Capricor Therapeutics, Inc